Copyright
©The Author(s) 2016.
World J Gastroenterol. Oct 7, 2016; 22(37): 8283-8293
Published online Oct 7, 2016. doi: 10.3748/wjg.v22.i37.8283
Published online Oct 7, 2016. doi: 10.3748/wjg.v22.i37.8283
Table 1 Summary of recent proteomic analyses of gastric cancer
Sample | Measurand | Mass spectrometry | Identification/quantification | Ref. |
Tissue samples | ||||
GC tissue | Global proteome | MALDI TOF/TOF, LTQ Orbitrap XL | Label-free, Mascot | Balluff et al[16], 2011 |
GC tissue | Global proteome | Q-TOF | O18/O16, MassLynx (v4.0) | Zhang et al[73], 2013 |
GC tissue | Global proteome | LTQ Orbitrap | Label-free, ProLuCID (v1.3) | Aquino et al[74], 2014 |
GC tissue | Global proteome | MALDI TOF/TOF | Label-free, Mascot (v2.2) | Wu et al[75], 2014 |
GC tissue | Global proteome | LTQ Orbitrap XL | Label-free, Mascot (v2.2) | Ichikawa et al[38], 2015 |
GC tissue | Global proteome | LTQ Orbitrap XL | Label-free, Bioworks Browser (v3.3.1), Trans-Proteomic Pipeline (v4.0) | Shen et al[76], 2015 |
GC tissue | Membrane proteome | LTQ Orbitrap Velos | TMT, MaxQuant (v1.2.2.5) | Gao et al[31], 2015 |
Gastroesophageal malignancy | Global proteome | MALDI TOF/TOF | iTRAQ, Mascot | Singhal et al[14], 2013 |
Serum samples | ||||
Sera from GC patients | Serum proteome | MALDI-TOF LTQ Orbitrap XL MS/MS | Label-free, Autoflex, Peptide mass fingerprinting | Fan et al[37], 2013 |
Sera from GC patients | Serum proteome | Triple TOF 5600 | Multiple reaction monitoring | Humphries et al[59], 2014 |
Sera from GC patients | Serum proteome | MALDI-TOF Orbitrap Q-Exactive | Label-free, MaxQuant (v1.4.1.1) | Abramowicz et al[50], 2015 |
Sera from GC patients | Serum proteome | LTQ Orbitrap Velos | iTRAQ, SEQUSET HT, Mascot (v2.2) | Subbannayya et al[29], 2015 |
Sera from GC patients | Serum proteome | SELDI TOF MS MALDI TOF/TOF | Label-free, Mascot | Song et al[17], 2016 |
Cell lines | ||||
BGC823, MKN45, SCG7901 | Global proteome | MALDI TOF/TOF | Label-free, Mascot | Cai et al[71], 2013 |
AGS, AZ521, FU97, MKN7, MKN74, NCI-N87, SNU16, YCC1, YCC2, YCC3, YCC9 | Global proteome | MALDI TOF/TOF | iTRAQ, ProteinPilot | Hou et al[69], 2013 |
AGS | Global proteome | Q-TOF | iTRAQ, Mascot (v2.1.1) | Hu et al[72], 2013 |
MKN45 | Global proteome | MALDI TOF/TOF | Label-free, Mascot | Hu et al[13], 2013 |
OCUM-2MD3, OCUM-12 | Global proteome | Q-TOF | iTRAQ, ProteinPilot | Morisaki et al[28], 2014 |
AGS, BGC823, MKN45, SGC7901 | Global proteome | MALDI TOF/TOF | Label-free, Peptide mass fingerprinting | Yang et al[67], 2014 |
HGC27, MGC803, SGC7901 | Global proteome | LTQ Orbitrap | Label-free, Mascot (v2.3.2), Scaffold (v4.0.5), X! Tandem CYCLONE (v2010.12.01.1) | Qiao et al[62], 2015 |
AGS | Global proteome | Q-TOF | iTRAQ, Mascot (v2.3.2) | Lin et al[61], 2015 |
HGC27 | Global proteome | Triple TOF 5600 | iTRAQ, Mascot (v2.3.2) | Chen et al[77], 2016 |
AGS, MKN7 | Secretome | MALDI TOF/TOF | iTRAQ, ProteinPilot | Loei et al[51], 2011 |
AGS, KATO III, NCI-N87, SNU1, SNU5, SNU16 | Secretome | LTQ Orbitrap Velos | SILAC, Proteome Discoverer (v1.3.0.339), Mascot, SEQUEST | Marimuthu et al[33], 2013 |
AGS, KATO III, SNU1, SNU5, MKN7, IM95 | Membrane proteome | LTQ-FT Ultra | Label-free, Trans-Proteomic Pipeline, Mascot (v2.2.07) | Guo et al[68], 2012 |
AGS, IM95, KATO3, MKN7, MKN28, MKN45, NUGC3, NUGC4, SCH, SNU1, SNU5, SNU16 | Membrane proteome | Q-TOF | iTRAQ, ProteinPilot | Yang et al[70], 2012 |
AGS, HGC27, KATO III, MKN45, NUGC3, SCH, SGC7901, SNU5, SNU484, TSK1 | Membrane proteome | Q-TOF | iTRAQ, ProteinPilot | Goh et al[60], 2015 |
Multidrug-resistant GC cell lines: GC7901/VCR, SGC7902/ADR | Surface glycoproteome | LTQ Orbitrap XL | Triplex stable isotope dimethyl labeling, Mascot, MSQuant (v2.0a81) | Li et al[47], 2013 |
AGS | Interactome | LTQ Orbitrap Velos | Label-free, Mascot (v2.2.2) | Yu et al[57], 2013 |
AGS | Phosphoproteome | MALDI TOF/TOF | SILAC, Mascot (v2.1) | Holland et al[43], 2011 |
AGS | Phosphoproteome | LTQ Orbitrap XL | SILAC, MaxQuant (v1.3.0.5) | Glowinski et al[42], 2014 |
- Citation: Kang C, Lee Y, Lee JE. Recent advances in mass spectrometry-based proteomics of gastric cancer. World J Gastroenterol 2016; 22(37): 8283-8293
- URL: https://www.wjgnet.com/1007-9327/full/v22/i37/8283.htm
- DOI: https://dx.doi.org/10.3748/wjg.v22.i37.8283